Pembrolizumab plus olaparib safe, active in docetaxel-pretreated men with prostate cancer Medical Health News, 28 Feb 2019 The KEYNOTE-365 trial is designed to assess the safety and efficacy of pembrolizumab in four different combinations in phase 1b/p…